Delivery Order SPE2DB20D2002-SPE2DB22FL04E
- Not listed
- This federal contract award is for the supply of BROMSITE 0.075% EYE DROPS 5ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $2,846.00. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 3, 2023. This contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,615.05 for the supply of 4556120380 - BROMSITE 0.075% EYE DROPS 5ML. The award was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 2, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Bromsite 0.075% eye drops. The contract, valued at $3,547.25, is a firm fixed-price delivery order with a completion date of December 11, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, with ID SPE2DB20D2002|SPE2DB21FL59L, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $21,404.50 fixed-price delivery order is for the supply of BROMSITE 0.075% eye drops, a pharmaceutical product, to support military and government healthcare programs. The contract is not designated under any set-aside program, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $3,496.61 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a pharmaceutical distribution subsidiary of Cencora, Inc. The contract is for the supply of Bromsite 0.075% eye drops, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which enables the company to provide a comprehensive range of pharmaceutical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BROMSITE 0.075% eye drops in 5mL bottles, with a ceiling value of $7,789.71 and a completion date of August 17, 2023. The contract has a firm fixed price pricing type and is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,577.96 firm fixed-price delivery order is for the supply of 4556402973 - BROMSITE 0.075% EYE DROPS 5ML. The contract has a completion date of March 1, 2022 and was awarded on February 28, 2022. No set-aside designation was used for this open competition contract. Amerisourcebergen Drug Corp is a subsidiary of...
- This federal contract award is for the delivery of 4557802497 BROMSITE 0.075% EYE DROPS 5ML. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award has a ceiling value of $7,037.99 and an ultimate completion date of July 18, 2022. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
- This federal contract award, valued at $3,824.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4557054812 - BROMSITE 0.075% EYE DROPS 5ML, a pharmaceutical product. The award has an ultimate completion date of May 2, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through...
- This federal contract award, valued at $3,032.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BROMSITE 0.075% EYE DROPS 5ML, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an Ultimate Completion Date of June 3, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL04EDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of BROMSITE 0.075% eye drops. The $4,112.11 firm-fixed-price contract has a completion date of November 30, 2021 and was awarded on November 29, 2021. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that maintains several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, collectively valued at up to $1.75 billion, to provide a wide range of pharmaceutical products and medical supplies to support federal healthcare programs, including those serving the military and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 11/29/21 |